Human Growth Hormone Market Report and Forecast 2025-2034
Description
The global human growth hormone market size was valued at USD 5.64 Billion in 2024, driven by the rising deficiency of growth hormones and associated conditions across the globe. The market is anticipated to grow at a CAGR of 8.50% during the forecast period of 2025-2034 to achieve a value of USD 12.75 Billion by 2034.
Human Growth Hormone: Introduction
Human growth hormone (HGH) is a hormone which is secreted naturally by pituitary gland in the brain. It is also called as somatotrophin. It is responsible for regulating and stimulating growth in kids, and help in regulating multiple psychological processes in adults as well. Human growth hormone is responsible for the overall health of an individual be that a kid or an adult. It takes care of the muscle growth, bone growth, performance of metabolism, along with repairing of cells and tissues in body. Synthetic versions of human growth hormones, also known as recombinant human growth hormone (rhGH), are used for medical purposes. These synthetic versions of human growth hormone are widely prescribed to treat conditions such as growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, and chronic kidney disease.
Additionally, it is sometimes used off-label for conditions like muscle wasting associated with HIV/AIDS or for anti-aging purposes. It is also used illicitly in the sports community for performance enhancement. However, the use of human growth hormone is prohibited for such purposes in sports business it is considered as doping by the authorities.
Global Human Growth Hormone Market Analysis
The reason for a child's rapid growth in their childhood and adolescence is the high production of this hormone during that time. However, with time the secretion of this hormone starts to reduce, resulting in decline of all the health factors that are associated with it such as cell and tissue repairing, metabolism, bone density and muscle mass. The decline in the secretion is considered to be associated with the aging process and factors associated with aging.
There are several trends leading the human growth hormone market growth, including the increased demand of human growth hormone therapy. The market is recording evident growth as the demand for human growth hormone therapies has been booming due the rising desire to enhance the performance and slow down aging, and other issue related to age.
Additionally, the ongoing research on development of alternate delivery methods in order to increase the patient convenience and compliance is also anticipated to aid the human growth hormone market development.
Some other key trends in the market include the proper surveillance for the appropriate uses and regulation of human growth hormones in the market, increasing emphasis on the personalized medicine and treatments, increasing focus on the potential of human growth hormone in fields other than deficiency recovery and growth factors such as sports medicine, anti-ageing and some other.
Human Growth Hormone Market Segmentation
“Human Growth Hormone Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Application
The market for human growth hormone has been witnessing evident growth in the past and is expected to see the growth in coming years as well. There factors driving the market growth are rising deficiency of growth hormones and associated conditions. This increase in deficiency is also aiding the global human growth hormone market expansion. Due to the technological advancement in the field, the availability has increased and has become more affordable. With the advanced development in recombinant DNA technology, the manufacturing of synthetic hormone has been introduced and put to practical use as well.
Additionally, the increasing awareness and knowledge on the merits of human growth hormone on physical performance, body composition and overall well-being are also likely to aid the market growth.
Human Growth Hormone Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
Human Growth Hormone: Introduction
Human growth hormone (HGH) is a hormone which is secreted naturally by pituitary gland in the brain. It is also called as somatotrophin. It is responsible for regulating and stimulating growth in kids, and help in regulating multiple psychological processes in adults as well. Human growth hormone is responsible for the overall health of an individual be that a kid or an adult. It takes care of the muscle growth, bone growth, performance of metabolism, along with repairing of cells and tissues in body. Synthetic versions of human growth hormones, also known as recombinant human growth hormone (rhGH), are used for medical purposes. These synthetic versions of human growth hormone are widely prescribed to treat conditions such as growth hormone deficiency, Turner syndrome, Prader-Willi syndrome, and chronic kidney disease.
Additionally, it is sometimes used off-label for conditions like muscle wasting associated with HIV/AIDS or for anti-aging purposes. It is also used illicitly in the sports community for performance enhancement. However, the use of human growth hormone is prohibited for such purposes in sports business it is considered as doping by the authorities.
Global Human Growth Hormone Market Analysis
The reason for a child's rapid growth in their childhood and adolescence is the high production of this hormone during that time. However, with time the secretion of this hormone starts to reduce, resulting in decline of all the health factors that are associated with it such as cell and tissue repairing, metabolism, bone density and muscle mass. The decline in the secretion is considered to be associated with the aging process and factors associated with aging.
There are several trends leading the human growth hormone market growth, including the increased demand of human growth hormone therapy. The market is recording evident growth as the demand for human growth hormone therapies has been booming due the rising desire to enhance the performance and slow down aging, and other issue related to age.
Additionally, the ongoing research on development of alternate delivery methods in order to increase the patient convenience and compliance is also anticipated to aid the human growth hormone market development.
Some other key trends in the market include the proper surveillance for the appropriate uses and regulation of human growth hormones in the market, increasing emphasis on the personalized medicine and treatments, increasing focus on the potential of human growth hormone in fields other than deficiency recovery and growth factors such as sports medicine, anti-ageing and some other.
Human Growth Hormone Market Segmentation
“Human Growth Hormone Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:
Market Breakup by Application
- Growth Hormone Deficiency
- Turner Syndrome
- Idiopathic Short Stature
- Prader-Willi Syndrome
- Other Applications
- Hospitals and Retail Pharmacies
- Online Pharmacies
- Other Distribution Channels
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
The market for human growth hormone has been witnessing evident growth in the past and is expected to see the growth in coming years as well. There factors driving the market growth are rising deficiency of growth hormones and associated conditions. This increase in deficiency is also aiding the global human growth hormone market expansion. Due to the technological advancement in the field, the availability has increased and has become more affordable. With the advanced development in recombinant DNA technology, the manufacturing of synthetic hormone has been introduced and put to practical use as well.
Additionally, the increasing awareness and knowledge on the merits of human growth hormone on physical performance, body composition and overall well-being are also likely to aid the market growth.
Human Growth Hormone Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- AnkeBio Co. Ltd
- Eli Lilly and Company
- Ferring BV
- Novo Nordisk AS
- Ipsen SA
- Pfizer Inc.
- Genentech Inc. (Roche)
- Teva Pharmaceutical Industries Ltd.
- Ferring BV
- Anhui Anke Biotechnology (Group) Co.
Table of Contents
350 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Human Growth Hormone Market Overview
- 3.1 Global Human Growth Hormone Market Historical Value (2018-2024)
- 3.2 Global Human Growth Hormone Market Forecast Value (2025-2034)
- 4 Global Human Growth Hormone Market Landscape
- 4.1 Human Growth Hormone Devices: Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Human Growth Hormone Devices: Product Landscape
- 4.2.1 Analysis by Age Group
- 4.2.2 Analysis by Applications
- 5 Global Human Growth Hormone Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Human Growth Hormone Market Segmentation
- 6.1 Global Human Growth Hormone Market by Application
- 6.1.1 Market Overview
- 6.1.2 Growth Hormone Deficiency
- 6.1.3 Turner Syndrome
- 6.1.4 Idiopathic Short Stature
- 6.1.5 Prader-Willi Syndrome
- 6.1.6 Other Applications
- 6.2 Global Human Growth Hormone Market by Distribution Channel
- 6.2.1 Market Overview
- 6.2.2 Hospitals and Retail Pharmacies
- 6.2.3 Online Pharmacies
- 6.2.4 Other Distribution Channels
- 6.3 Global Human Growth Hormone Market by Region
- 6.3.1 Market Overview
- 6.3.2 North America
- 6.3.3 Europe
- 6.3.4 Asia Pacific
- 6.3.5 Latin America
- 6.3.6 Middle East and Africa
- 7 North America Growth Hormone Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Human Growth Hormone Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Human Growth Hormone Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Human Growth Hormone Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Human Growth Hormone Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Regulatory Framework
- 12.1 Regulatory Overview
- 12.1.1 US FDA
- 12.1.2 EU EMA
- 12.1.3 INDIA CDSCO
- 12.1.4 JAPAN PMDA
- 12.1.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 13.7 Analysis by Key Players
- 14 Grants Analysis
- 14.1 Analysis by year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Application
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Clinical Trials Analysis
- 15.1 Analysis by Trial Registration Year
- 15.2 Analysis by Trial Status
- 15.3 Analysis by Trial Phase
- 15.4 Analysis by Therapeutic Area
- 15.5 Analysis by Geography
- 16 Funding and Investment Analysis
- 16.1 Analysis by Funding Instances
- 16.2 Analysis by Type of Funding
- 16.3 Analysis by Funding Amount
- 16.4 Analysis by Leading Players
- 16.5 Analysis by Leading Investors
- 16.6 Analysis by Geography
- 17 Partnership and Collaborations Analysis
- 17.1 Analysis by Partnership Instances
- 17.2 Analysis by Type of Partnership
- 17.3 Analysis by Leading Players
- 17.4 Analysis by Geography
- 18 Supplier Landscape
- 18.1 AnkeBio Co. Ltd
- 18.1.1 Financial Analysis
- 18.1.2 Product Portfolio
- 18.1.3 Demographic Reach and Achievements
- 18.1.4 Mergers and Acquisitions
- 18.1.5 Certifications
- 18.2 Eli Lilly and Company
- 18.2.1 Financial Analysis
- 18.2.2 Product Portfolio
- 18.2.3 Demographic Reach and Achievements
- 18.2.4 Mergers and Acquisitions
- 18.2.5 Certifications
- 18.3 Ferring BV
- 18.3.1 Financial Analysis
- 18.3.2 Product Portfolio
- 18.3.3 Demographic Reach and Achievements
- 18.3.4 Mergers and Acquisitions
- 18.3.5 Certifications
- 18.4 Novo Nordisk AS
- 18.4.1 Financial Analysis
- 18.4.2 Product Portfolio
- 18.4.3 Demographic Reach and Achievements
- 18.4.4 Mergers and Acquisitions
- 18.4.5 Certifications
- 18.5 Ipsen SA
- 18.5.1 Financial Analysis
- 18.5.2 Product Portfolio
- 18.5.3 Demographic Reach and Achievements
- 18.5.4 Mergers and Acquisitions
- 18.5.5 Certifications
- 18.6 Pfizer Inc.
- 18.6.1 Financial Analysis
- 18.6.2 Product Portfolio
- 18.6.3 Demographic Reach and Achievements
- 18.6.4 Mergers and Acquisitions
- 18.6.5 Certifications
- 18.7 Genentech Inc. (Roche)
- 18.7.1 Financial Analysis
- 18.7.2 Product Portfolio
- 18.7.3 Demographic Reach and Achievements
- 18.7.4 Mergers and Acquisitions
- 18.7.5 Certifications
- 18.8 Teva Pharmaceutical Industries Ltd.
- 18.8.1 Financial Analysis
- 18.8.2 Product Portfolio
- 18.8.3 Demographic Reach and Achievements
- 18.8.4 Mergers and Acquisitions
- 18.8.5 Certifications
- 18.9 Ferring BV
- 18.9.1 Financial Analysis
- 18.9.2 Product Portfolio
- 18.9.3 Demographic Reach and Achievements
- 18.9.4 Mergers and Acquisitions
- 18.9.5 Certifications
- 18.10 Anhui Anke Biotechnology (Group) Co.
- 18.10.1 Financial Analysis
- 18.10.2 Product Portfolio
- 18.10.3 Demographic Reach and Achievements
- 18.10.4 Mergers and Acquisitions
- 18.10.5 Certifications
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
